(Q38025185)

27 August 2017

title

Cardiovascular disease in chronic kidney disease: untying the Gordian knot (English)

1 reference

chronic renal insufficiency

27 August 2017

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

R Hajhosseiny

1

1 reference

27 August 2017

K Khavandi

series ordinal

2

1 reference

27 August 2017

D J Goldsmith

series ordinal

3

1 reference

27 August 2017

language of work or name

1 reference

11 July 2012

1 reference

International Journal of Clinical Practice

27 August 2017

published in

1 reference

27 August 2017

volume

67

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

14-31

1 reference

Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Is it time to measure microalbuminuria in hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The role of asymmetric and symmetric dimethylarginines in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Abnormalities of endothelial function in patients with predialysis renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Endothelial dysfunction in renal transplant recipients maintained on cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Lipoprotein lipase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac autonomic neuropathy in diabetes: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Diabetic cardiomyopathy--a distinct disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Kidney dysfunction and sudden cardiac death among women with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The independent association of renal dysfunction and arrhythmias in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Coronary artery disease in uremia: Etiology, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Association of chronic kidney disease and coronary artery disease in 1,010 consecutive patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: Ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac troponins in renal insufficiency: review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Vascular smooth muscle cells in the pathogenesis of vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Vascular calcification: in vitro evidence for the role of inorganic phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The mechanism of phosphorus as a cardiovascular risk factor in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Clinical relevance of FGF-23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Does FGF23 toxicity influence the outcome of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Dysregulation of renal vitamin D metabolism in the uremic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Vitamin D and human health: lessons from vitamin D receptor null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Calcitriol modulation of cardiac contractile performance via protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiovascular risk factors in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Homocysteine lowering and cardiovascular disease risk: lost in translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Nephrotic syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effect of statins on the development of renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Sudden cardiac death in hemodialysis patients: an in-depth review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Antioxidant therapy in hemodialysis patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Sudden cardiac death in chronic kidney disease: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: the Honolulu Heart Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Poor long-term survival after coronary angiography in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Electrocardiographic abnormalities and uremic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Screening for Coronary Artery Disease Before Renal Transplantation—Rational or Rationing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

Blood pressure in chronic kidney disease stage 5D—report from a Kidney Disease: Improving Global Outcomes controversies conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.02954.X

10.1111/J.1742-1241.2012.02954.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference